By: IPP Bureau
Last updated : July 27, 2026 1:33 pm
Sculptra uses a unique formulation to stimulate the body’s own collagen production, helping rebuild the skin’s underlying structure and address collagen loss associated with ageing
Galderma, a pure-play dermatology company, has announced the launch of Sculptra in India, introducing the country to a regenerative biostimulator designed to stimulate the body’s natural collagen production and deliver gradual, natural-looking improvements in facial volume and skin quality.
Supported by more than 25 years of clinical evidence globally, Sculptra represents a new generation of injectable aesthetics that moves beyond temporary correction by working with the body’s own biological processes to restore facial structure, improve skin quality, and provide long-lasting results when administered by qualified healthcare professionals.
The launch comes at a time when India’s aesthetics market is witnessing growing demand for minimally invasive, personalised solutions focused on skin health and natural outcomes. Increasingly, patients and healthcare professionals are shifting towards regenerative approaches that enhance and preserve natural features rather than offering immediate corrective changes.
Raghavendra Sadashiva, Managing Director, Galderma India & South Asia, said, “At Galderma, our focus has always been on bringing science-led innovations that address the evolving needs of healthcare professionals and patients. The introduction of Sculptra marks an important milestone for India’s aesthetics landscape as regenerative dermatology gains momentum globally.”
“By working with the body’s natural collagen production, Sculptra supports gradual, natural-looking improvements in skin quality and facial structure. We are proud to bring this globally trusted innovation to India and strengthen our commitment to advancing dermatological science in the country,” added Sadashiva.
Sculptra uses its proprietary PLLA-SCA formulation to stimulate the body’s own collagen production, helping rebuild the skin’s underlying structure and address collagen loss associated with ageing.
Ravi Mittal, Business Unit Head, Aesthetics, Galderma India, said, “We are witnessing a shift from correction towards regeneration, where collagen stimulation and skin quality are becoming central to aesthetic decisions. Sculptra marks an important step in bringing regenerative aesthetics to India by offering clinicians a science-backed option that works with the body’s natural processes.”